Vanguard Group Inc Axonics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Axonics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,064,595 shares of AXNX stock, worth $359 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,064,595

Previous 5,041,294 0.46%

Holding current value

$359 Million

Previous $339 Million 4.11%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$67.3 - $69.67 $1.57 Million - $1.62 Million	23,301 Added 0.46%	5,064,595 $353 Million
Q2 2024 Aug 13, 2024	SELL	$66.47 - $69.65 $37,489 - $39,282	-564 Reduced 0.01%	5,041,294 $339 Million
Q1 2024 May 10, 2024	SELL	$56.67 - $69.36 $12.4 Million - $15.2 Million	-218,972 Reduced 4.16%	5,041,858 $348 Million
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $73,279 - $94,605	-1,484 Reduced 0.03%	5,260,830 $327 Million
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $3.5 Million - $4.5 Million	-72,029 Reduced 1.35%	5,262,314 $295 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $7.55 Million - $9.48 Million	157,380 Added 3.04%	5,334,343 $269 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $16.5 Million - $21.1 Million	313,680 Added 6.45%	5,176,963 $282 Million
Q4 2022 Feb 10, 2023	BUY	$59.56 - $76.6 $47 Million - $60.5 Million	789,810 Added 19.39%	4,863,283 $304 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $57.4 Million - $77.4 Million	991,055 Added 32.15%	4,073,473 $287 Million
Q2 2022 Aug 12, 2022	BUY	$39.5 - $64.42 $10.6 Million - $17.3 Million	268,555 Added 9.54%	3,082,418 $175 Million
Q1 2022 May 13, 2022	SELL	$43.74 - $62.76 $3.89 Million - $5.58 Million	-88,833 Reduced 3.06%	2,813,863 $176 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $1.26 Million - $1.85 Million	25,166 Added 0.87%	2,902,696 $163 Million
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $61.8 Million - $82.2 Million	1,044,453 Added 56.98%	2,877,530 $187 Million
Q2 2021 Aug 13, 2021	BUY	$51.39 - $66.9 $94.2 Million - $123 Million	1,833,077 New	1,833,077 $116 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Axonics, Inc. Transaction History